Literature DB >> 21666155

The Measles Initiative: moving toward measles eradication.

Athalia S Christie1, Andrea Gay.   

Abstract

The World Health Assembly should establish a target date for measles eradication based on continued progress toward existing mortality reduction goals. We have a safe, effective, and inexpensive vaccine; a proven elimination strategy; high country demand; and an effective global partnership. Since it was founded in 2001, the Measles Initiative has supported the vaccination of >900 million children in supplementary immunization activities. Largely as a result, global measles deaths decreased by 78% between 2000 and 2008, averting an estimated 4.3 million deaths. The Measles Initiative has exceeded its targets and evolved to address increasingly ambitious goals. The current challenges include a decline in funding and weak routine immunization systems in some countries. Skeptics of measles eradication raise 3 main objections: the yet-to-be-achieved polio eradication goal, the high cost, and the impact on health systems. These are important concerns that can be addressed with judicious program planning. All 6 World Health Organization regions have committed to measles elimination, and 5 have set a target date. The World Health Assembly has endorsed interim targets toward eradication, and an independent global measles advisory group has determined measles can and should be eradicated. A target date for eradication will focus efforts and capitalize on the achievements of the last decade. Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2011.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21666155     DOI: 10.1093/infdis/jir075

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  8 in total

1.  Vaccine refusal and the endgame: walking the last mile first.

Authors:  Diane S Saint-Victor; Saad B Omer
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-06-24       Impact factor: 6.237

2.  Fifty Years of Global Immunization at CDC, 1966-2015.

Authors:  Eric E Mast; Stephen L Cochi; Olen M Kew; K Lisa Cairns; Peter B Bloland; Rebecca Martin
Journal:  Public Health Rep       Date:  2016-12-19       Impact factor: 2.792

3.  Overview of global, regional, and national routine vaccination coverage trends and growth patterns from 1980 to 2009: implications for vaccine-preventable disease eradication and elimination initiatives.

Authors:  Aaron S Wallace; Tove K Ryman; Vance Dietz
Journal:  J Infect Dis       Date:  2014-11-01       Impact factor: 5.226

4.  The effects of maternal immunity and age structure on population immunity to measles.

Authors:  A McKee; M J Ferrari; K Shea
Journal:  Theor Ecol       Date:  2015-05       Impact factor: 1.432

5.  Measles vaccination coverage estimates from surveys, clinic records, and immune markers in oral fluid and blood: a population-based cross-sectional study.

Authors:  Kyla T Hayford; Mohammed S Shomik; Hassan M Al-Emran; William J Moss; David Bishai; Orin S Levine
Journal:  BMC Public Health       Date:  2013-12-20       Impact factor: 3.295

6.  Demographic transition and the dynamics of measles in six provinces in China: A modeling study.

Authors:  Sheng Li; Chao Ma; Lixin Hao; Qiru Su; Zhijie An; Fubao Ma; Shuyun Xie; Aiqiang Xu; Yanyang Zhang; Zhengrong Ding; Hui Li; Lisa Cairns; Huaqing Wang; Huiming Luo; Ning Wang; Li Li; Matthew J Ferrari
Journal:  PLoS Med       Date:  2017-04-04       Impact factor: 11.069

7.  Description of a large measles epidemic in Democratic Republic of Congo, 2010-2013.

Authors:  Silvia Mancini; Matthew E Coldiron; Axelle Ronsse; Benoît Kebela Ilunga; Klaudia Porten; Rebecca F Grais
Journal:  Confl Health       Date:  2014-07-03       Impact factor: 2.723

8.  A 'post-honeymoon' measles epidemic in Burundi: mathematical model-based analysis and implications for vaccination timing.

Authors:  Katelyn C Corey; Andrew Noymer
Journal:  PeerJ       Date:  2016-09-15       Impact factor: 2.984

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.